Gurbakhash Kaur
- Co-authors
- Hao WangXingxing ZangAlexander SankinFuxiang ChenFangxia GuanMurali JanakiramLarry D. AndersonAimaz Afrough
- Topics
- Multiple Myeloma Research and Treatments (19 papers)CAR-T cell therapy research (11 papers)Protein Degradation and Inhibitors (9 papers)
- Cited by
- HematologyOncologyImmunology
- Journals
- Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesAustraliaIndia
In The Last Decade
Gurbakhash Kaur
30 papers receiving 345 citations
Peers
Comparison fields: 5 of 66
- Oncology 221
- Molecular Biology 135
- Hematology 103
- Immunology 101
- Biomedical Engineering 48
Countries citing papers authored by Gurbakhash Kaur
This map shows the geographic impact of Gurbakhash Kaur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gurbakhash Kaur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gurbakhash Kaur more than expected).
Fields of papers citing papers by Gurbakhash Kaur
This network shows the impact of papers produced by Gurbakhash Kaur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gurbakhash Kaur. The network helps show where Gurbakhash Kaur may publish in the future.
Co-authorship network of co-authors of Gurbakhash Kaur
This figure shows the co-authorship network connecting the top 25 collaborators of Gurbakhash Kaur. A scholar is included among the top collaborators of Gurbakhash Kaur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gurbakhash Kaur. Gurbakhash Kaur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 32 | |
| 7 | 0 | |
| 8 | 1 | |
| 9 | 9 | |
| 10 | 1 | |
| 11 | 7 | |
| 12 | 1 | |
| 13 | 1 | |
| 14 | 1 | |
| 15 | 40 | |
| 16 | 0 | |
| 17 | 15 | |
| 18 | 0 | |
| 19 | 15 | |
| 20 | 152 |
About Gurbakhash Kaur
Gurbakhash Kaur is a scholar working on Hematology, Oncology and Genetics, having authored 39 papers that have together received 350 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (19 papers), CAR-T cell therapy research (11 papers) and Protein Degradation and Inhibitors (9 papers). The work is most often cited by research in Hematology (103 citations), Oncology (221 citations) and Immunology (101 citations). Gurbakhash Kaur has collaborated with scholars based in United States, Australia and India. Frequent co-authors include Hao Wang, Xingxing Zang, Alexander Sankin, Fuxiang Chen, Fangxia Guan, Murali Janakiram, Larry D. Anderson, Aimaz Afrough, Zahra Mahmoudjafari and Jason Valent. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.